GenVec Awarded Grant for Antigen Discovery Project
GAITHERSBURG, Md., March 26, 2012 /PRNewswire via COMTEX/ -- GenVec, Inc. (GNVC)
announced today that it has received a grant from the National Institute of
Allergy and Infectious Diseases (NIAID) of the National Institutes of Health
(NIH) under Award Number R43AI100467 to support the company's malaria vaccine
program.
"We appreciate the support this grant offers GenVec. Our technology to discover
new antigens is showing promise and this grant will further our efforts in this
area to identify novel antigens for malaria vaccine development," said Dr. Joseph
Bruder, Director of Research and head of GenVec's malaria program.
This grant, valued at approximately $600,000 over two years, will be used to
identify novel highly protective antigens for malaria vaccine development. The
work under this grant will build on the research that was started under a Small
Business Innovation and Research (SBIR) grant from the NIAID in 2009. GenVec will
be collaborating with the U.S. Naval Medical Research Center (NMRC) to apply its
adenovector technology to the development of malaria vaccine candidates.
---
GenVec presented 'promising' data on RSV Program at the 'Keystone Symposium on Viral Immunity and Host Gene Influence'
Co announced that data were presented on GenVec's respiratory syncytial virus vaccine program at the 'Keystone Symposium on Viral Immunity and Host Gene Influence', which is taking place in Keystone, Colorado from Mar 21-26, 2012. The data were generated by the VRC and GenVec under a Cooperative Research and Development Agreement. Data presented at the conference demonstrated encouraging preclinical proof-of-concept findings generated in non-human primates. Specifically, the data show GenVec's vaccine technology induced neutralizing antibody, and significant T-cell responses with a single administration. The immune responses were consistent with protective responses without disease potentiation and multiple administrations increased the neutralizing antibody responses. |
